Travelers Vaccines Market Outlook and Forecast Analysis by Types to 2021
Global
Travelers Vaccines Market is
segmented on the basis of product types, application and geography. The agent
stimulates the immune system of the body for identifying the agent as foreign,
destroying it, and “remembering” it, so that the immune system could easily
recognize and destroy any of these microorganisms that it later encounters is
termed as a vaccine.
Access Travelers Vaccines Market Report with TOC @ https://www.millioninsights.com/industry-reports/travellers-vaccines-market
The
introduction of additional age group coverage is one of the primary factors
driving the travelers vaccines market’s growth. While approving a vaccine, the
regulatory authorities also specify the age group approved for receiving the
vaccine. This age group is particular on the vaccine label and is based on the efficacy
and safety results obtained from clinical trials conducted using individuals
from these age groups. Label expansion to include additional age groups
approved for immunization requires additional regulatory approval.
These
approvals are based on the additional clinical trials conducted using
individuals from additional age groups. The increase in approvals for
additional age group coverage will increase the patient population for the
vaccine, thereby propelling the travelers vaccines market’s growth in the
coming years. Based on product types, the travelers vaccines market is
classified as japanese encephalitis vaccine, meningococcal vaccine, rabies
vaccine, yellow fever vaccine, typhoid vaccine, hepatitis B vaccine, hepatitis
A vaccine, cholera vaccine, combination vaccine and mono vaccine.
The
segment “combination vaccines” is one of the fastest rising segments of the
travelers vaccines market. These vaccines present protection against different
causative agents for diseases such as meningitis, measles, rubella, mumps,
diphtheria, pertussis and tetanus.
Menhibrix and Menitronix are the most commonly used combination
vaccines. While Menhibrix is approved for the prevention of invasive disease
caused by Haemophilus influenzae type b and N, meningitidis serogroups C and Y.
Menitronix is approved for the prevention of invasive diseases caused by N.
meningitidis serogroup C and H. influenzae type b. Moreover, combination
vaccines ensure better patient compliance, which will also contribute to this
segment’s growth in the coming years. Based on application, the travelers
vaccines market is classified as tourists, students, workers and so on.
Top Manufacturer Analysis Covered
in Travelers Vaccines Market Report includes
• GlaxoSmithKline/Novartis
•
Sanofi Pasteur
•
Pfizer
•
Merck
•
Sanofi Pasteur MSD
•
CNBG
•
Biokangtai
Segmentation on the basis of Product
Types,
•
Meningococcal Vaccine
•
Japanese Encephalitis Vaccine
•
Rabies Vaccine
•
Typhoid Vaccine
•
Yellow Fever Vaccine
•
Hepatitis B Vaccine
•
Hepatitis A Vaccine
•
Cholera Vaccine
•
Others Vaccines (Hepatitis E Vaccines, Tick-Borne Encephalitis Vaccine, etc.)
Segmentation on the basis of Applications,
•
Tourists
•
Students
•
Workers
•
Others
Request a Sample Copy of Travelers Vaccines Market Report @ https://www.millioninsights.com/industry-reports/travellers-vaccines-market/request-sample
Based
on geography, the travelers vaccines market is classified as Middle East &
Africa, Latin America, Europe, Asia Pacific and North America. The North
America was the highest profits contributing region in the market during 2015
and will continue to lead the market in the coming years. The U.S. was one of
the highest revenue contributors in the region, capturing a significant portion
of the market. The increasing demand for
vaccines that provide to the unmet medical needs provides an opportunity for
vendors to develop new safe and efficient molecules, which will assist in the
growth of the travelers vaccines market in the region.

Comments
Post a Comment